Cellworks Study Supports Liquid Biopsy for Predicting Chemo-Immunotherapy Benefit in Advanced NSCLC
New findings show potential for liquid biopsy to expand access to personalized treatment prediction in advanced NSCLC SAN DIEGO, CA, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- Cellworks Group Inc., the leader in Personalized Therapy Solutions …